Problem:
Respond to this statement: Today at the clinic, a Rexulti rep came and gave literature. This is a second-generation antipsychotic medication that per research shows very few side effects. Efficacy is noted at 1 week of taking it and covered by almost all insurances. This medication is used best for patients who have Depression plus Anxiety and he stated not for Resistant treatment Depression. Also, this medication does not have strict monitoring of labs like some of the first-generation antipsychotics. 50 percent of my preceptor's patients with the appropriate diagnosis currently taking this medication. She states that she has to highly educate the patients about the mechanism of action and tell them that it is considered an antipsychotic medication. Some still refuse it while others give it and gain symptom management.